---
schema_version: "secwatch.filing_event.v1"
accession: "0001171843-25-005206"
form_type: "8-K"
ticker: "UG"
cik: "0000101295"
company_name: "UNITED GUARDIAN INC"
filed_at: "2025-08-08T23:59:59+00:00"
generated_at: "2026-05-17T16:02:58.919704+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# United-Guardian Q2 net sales fall 16% YoY; EPS $0.14 vs $0.21

## Summary
- Q2 net sales $2.84M, down 16% YoY from $3.39M; net income $627K ($0.14) vs $956K ($0.21).
- H1 net sales $5.32M, down 20% YoY; net income $1.19M ($0.26) vs $1.88M ($0.41).
- Medical lubricants +12% and pharmaceuticals +11% in H1; cosmetic sales fell due to ASI inventory overstock in Asia.
- Q2 sequential improvement: sales +14% and net income +12% vs Q1 2025.
- Company pursuing Renacidin formulary expansion to boost pharmaceutical sales.

## SEC filing metadata
- accession: 0001171843-25-005206
- form_type: 8-K
- ticker: UG
- cik: 0000101295
- company_name: UNITED GUARDIAN INC
- filed_at: 2025-08-08T23:59:59+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/101295/000117184325005206/0001171843-25-005206-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/101295/000117184325005206/f8k_080725.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001171843-25-005206
- JSON: https://secwatch.observer/filing/0001171843-25-005206.json
- Plain text: https://secwatch.observer/filing/0001171843-25-005206.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.